STOCKSAbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis DrugBy Tony OwusuDec 3, 2019 10:06 AM EST
STOCKSAbbVie Affirmed Overweight at Piper Jaffray on Potential of Arthritis DrugBy Tony OwusuDec 3, 2019 10:06 AM EST
JIM CRAMERAbbVie, Nokia, Lululemon Athletica: 'Mad Money' Lightning RoundBy Scott RuttNov 21, 2019 8:39 PM EST
CORPORATE GOVERNANCEAbbott Labs Taps Operating Chief Robert Ford as CEO, Succeeding Miles WhiteBy Rob DanielNov 13, 2019 10:54 AM EST
INVESTINGAbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: ReportBy Scott Van VoorhisNov 12, 2019 10:00 AM EST
EARNINGSAllergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie TakeoverBy Martin BaccardaxNov 5, 2019 9:40 AM EST
INVESTINGAbbVie Posts Stronger-Than-Expected Earnings, Lifts ForecastBy M. Corey GoldmanNov 1, 2019 9:35 AM EDT
MARKETSJobs Report, Exxon, Pinterest, Amgen, U.S. Steel - 5 Things You Must Know FridayBy Joseph WoelfelNov 1, 2019 7:01 AM EDT
JIM CRAMERGreat Investors Need Good Judgment: Cramer's 'Mad Money' RecapBy Scott RuttOct 15, 2019 6:59 PM EDT
PERSONAL FINANCEDividend Investing: What Is It and How Does It Work?By Roger WohlnerSep 23, 2019 12:36 PM EDT
MARKETSBroadcom, WeWork, Dow Futures, China Trade, Cloudflare - 5 Things You Must KnowBy Joseph WoelfelSep 13, 2019 6:37 AM EDT
CANNABISAurora Cannabis Shares Drop Almost 10% in Late Trade After Quarterly ResultsBy Tom BemisSep 11, 2019 6:02 PM EDT
INVESTINGAs U.S. Interest Rates Head Lower, Here's What To Invest InBy Jason OrestesSep 3, 2019 12:22 PM EDT
INVESTINGAllergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid LitigationBy M. Corey GoldmanAug 30, 2019 9:39 AM EDT
STOCKSAbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung CancerBy Tony OwusuAug 29, 2019 1:29 PM EDT
JIM CRAMERUnion Pacific, Pfizer, Merck, AbbVie: 'Mad Money' Lightning RoundBy Scott RuttAug 21, 2019 8:43 PM EDT
JIM CRAMERTaking a Cue From Retailers: Cramer's 'Mad Money' RecapBy Scott RuttAug 21, 2019 8:39 PM EDT
CANNABISCannabis Stocks Fall: Tilray Up 10.4%; General Cannabis Off 5.3%By Tom BemisAug 21, 2019 6:06 PM EDT
